- Previous Close
0.1320 - Open
0.1320 - Bid 0.1290 x --
- Ask 0.1600 x --
- Day's Range
0.1320 - 0.1320 - 52 Week Range
0.1270 - 0.1850 - Volume
100,000 - Avg. Volume
18,477 - Market Cap (intraday)
17.16M - Beta (5Y Monthly) --
- PE Ratio (TTM)
13.20 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield 0.01 (7.58%)
- Ex-Dividend Date May 16, 2024
- 1y Target Est
--
Niks Professional Ltd., together with its subsidiaries, provides family practice dermatology and aesthetic medical services under the NIKS brand in Singapore. The company operates through three segments: Clinics, Retail, and Headquarters. It offers treatment for acne and acne scars, eczema, and pigmentation, as well as non-invasive and minimally invasive aesthetic medical services, including intense pulsed light treatment, various laser treatments, and injectables. The company also sells a range of medical skincare products to hospitals, clinics, pharmacies, retail shops, doctors, and consumers through regional agents, as well as through own channels, and online sale and distribution. In addition, it provides salon services, such as therapeutic facial treatment, eye treatment, acne and comedone treatment, and microdermabrasion. The company was incorporated in 1998 and is headquartered in Singapore.
www.nikspro.com52
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NPL.SI
View MorePerformance Overview: NPL.SI
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NPL.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NPL.SI
View MoreValuation Measures
Market Cap
17.16M
Enterprise Value
10.51M
Trailing P/E
11.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.57
Price/Book (mrq)
0.90
Enterprise Value/Revenue
0.96
Enterprise Value/EBITDA
3.53
Financial Highlights
Profitability and Income Statement
Profit Margin
13.63%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
11.16M
Net Income Avi to Common (ttm)
1.52M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
8.29M
Total Debt/Equity (mrq)
8.50%
Levered Free Cash Flow (ttm)
--